Cypherpunk Technologies Inc
CYPH
NASDAQ
Biotechnology
$0.64
USD
0.00 (-0.62%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $68.49M
Volume 562.0K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 4.1 | 4.7 | 4.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 5.1 | 4.8 | 4.7 |
Operating Income | -5.1 | -4.8 | -4.7 |
EBITDA | -5.1 | -4.8 | -4.7 |
Other Income / Expense | 50.3 | -77.6 | 46.0 |
Total Other Income / Expense | 50.4 | -77.5 | 46.1 |
Income Before Income Taxes | 45.3 | -82.3 | 41.4 |
Income Taxes | 5.1 | -5.1 | 2.0 |
Net Income | 40.2 | -77.2 | 39.4 |
Consolidated Net Income / Loss | 40.2 | -77.2 | 39.4 |
Net Income Attributable to Common Shareholders | 40.2 | -77.2 | 39.4 |
Basic EPS | $0.29 | -$0.46 | $0.21 |
Diluted EPS | $0.25 | -$0.46 | $0.18 |
Basic Shares Outstanding | 140.4M | 168.1M | 184.3M |
Diluted Shares Outstanding | 158.5M | 168.1M | 217.3M |